227P - Evaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes

Autor: Fasching, P.A., Laible, M., Weber, K.E., Wirtz, R.M., Denkert, C., Schlombs, K., Schmatloch, S., Camara, O., Lück, H.J., Huober, J., Karn, T., van Mackelenbergh, M.T., Marme, F., Müller, V., Schem, C., Stickeler, E., Sahin, U., Loibl, S., Untch, M.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect